http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012075440-A4

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6be95b04b3b1567c81d49d42db272042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fdf3946ad8b60620104d56f72595f07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dd9ecf94d026fd20f73bba2775dc6c3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e455a27366ca3e7bcc139ab7db86b11e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f64af8e58dcda1c61e37a7fe7667cb8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_29f455df0b1de833e2f055f93a201417
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e1517693b27c4005ccab75ff5f721d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1a331d46449cc0bf0e1e9b8bda91158f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4168
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
filingDate 2011-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04d1581ffe8c8de61385b0507abe974c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b378a9480553e7cb5f513a7d845feb1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d25bc85a9681f14c134572ea7ee3f4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c31043d58c53b42ecf3d1d91ae49b6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4670aa7feb3bfe253088f642413883f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_201ab8336128d30d7ab47904a851b6f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14b315f36c5d719049140c803becdfeb
publicationDate 2012-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2012075440-A4
titleOfInvention Compositions and methods for delivering clonidine to a target tissue site
abstract Effective treatments of pain for extended periods of time are provided. Through the administration of an effective amount of immediate release clonidine and a sustained release clonidine at or near a target site, one can relieve pain caused by diverse sources, including but not limited to spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discogenic back pain and joint pain. When appropriate formulations are provided within biodegradable polymers, this relief can be continued for at least three days. In some embodiments, the relief can be for at least twenty-five days, at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days or longer.
priorityDate 2010-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557772
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555351
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397536
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2803

Total number of triples: 32.